Table 2.

Effect of different dosage regimens of mycophenolate mofetil (MMF) on percentage of red blood cells (RBC%) and platelets in cats (n = 24)

Cat and dosage	RBC% pre-MMF	RBC% post-MMF	Platelet (200–500 ×103/μl) pre-MMF	Platelet (200–500 ×103 /µl) post-MMF
5 mg/kg IV once
1	33	23	144,000	109,000
2	30	32	51,000 (large platelets)	211,000
10 mg/kg IV q12h
3	51	46	140,000 (many aggregates)	15,000 (large platelets)
20 mg/kg IV q12h
4	43	30	175,000	299,000
5	44	36	339,000	167,000
6	40	36	330,000	61,000 (large platelets, many aggregates)
7	39	36	493,000	35,000 (platelet aggregates)
8	39	32	367,000	541,000
9	37	37	96,000 (many platelet aggregates)	485,000
10 mg/kg IV q12 × 3 days
10	40	29	372,000	91,000 (large platelets, aggregates)
11	33	30	494,000	105,000 (large platelets, aggregates)
12	35	35	590,000	72,000 (large platelets)
13	32	30	145,000 (platelet aggregates)	81,000
14	34	32	482,000	186,000 (large platelets)
10 mg/kg PO q12h × 1 week
15	48	32	212,000	187,000 (large platelets, aggregates)
16	33	32	390,000	222,000
17	39	34	380,000	161,000 (large platelets)
15 mg/kg PO q12h × 1 week
18	29	32	301,000 (platelet aggregates)	84,000
19	36	31	468,000 (large platelets)	90,000 (platelet aggregates)
20	39	34	250,000	43,000 (large platelets, many aggregates)
15 mg/kg PO q8h × 1 week
21	39	27	382,000	92,000 (large platelets)
22	36	31	304,000 (platelet aggregates)	163,000
23	26	26	190,000 (platelet aggregates)	207,000
24	29	28	219,000	96,000